massachusetts semaglutide Medical Weight Loss GLP-1 in (MA) Who Can Prescribe Semaglutide? Prescribers

It includes treatments for various medical conditions, such as type 1 and type 2 diabetes, obesity, hypogonadism (a condition where the bodys sex glands produce little or no hormones), dwarfism, hypo or hyperparathyroidism, acromegaly (abnormal growth of the hands, feet, and face, caused by the overproduction of growth hormone by the pituitary gland) and congenital adrenal hyperplasia (a genetic disorder that affects the adrenal glands)

As of March 2026, the FDA approved a maximum weekly dose of 7.2 mg for eligible adults

Every persons journey is unique

FDA's Decision and Its Implications The FDA's determination that semaglutide is no longer in shortage means that compounding pharmacies are expected to cease production of compounded semaglutide